Alitair Pharmaceuticals is Pharmaceuticals in United States that focus on prescription cough medicines business. Founded in 2010. They cover business area such as operator, proprietary ion-exchange resin formulation, prescription cough medicine, a pipeline, orphan drug, prescription drug, tablet, capsule, medical professional, bronchiectasis, patient, relief, respiration-relate disease.
2010
( 15 years old in 2025 )
Prescription Cough Medicines
-
55 Madison Avenue
Suite 400
Morristown, NJ 07960
United States
Private
operatorproprietary ion-exchange resin formulationprescription cough medicinea pipelineorphan drugprescription drugtabletcapsulemedical professionalbronchiectasispatientreliefrespiration-relate disease
* We use standard office opening hours in near Alitair Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Alitair Pharmaceuticals is Pharmaceuticals business from United States that founded in 2010 (15 years old in 2025), Alitair Pharmaceuticals business is focusing on Prescription Cough Medicines.
Alitair Pharmaceuticals headquarter office and corporate office address is located in 55 Madison Avenue Suite 400 Morristown, NJ 07960 United States.
Alitair Pharmaceuticals was founded in United States.
In 2025, Alitair Pharmaceuticals is currently focus on prescription cough medicines sector.
Above is snippet of Google Trends for "prescription cough medicines" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Alitair Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
